ACORI: ACCC Community Oncology Research Institute



Home / Learn / Research & Clinical Trials / ACCC Community Oncology Research Institute

ACCC Community Oncology Research Institute

The Association of Community Cancer Centers (ACCC) has established the ACCC Community Oncology Research Institute (ACORI) to build on its existing mission to close the gap in cancer research through optimal oncology partnerships. ACORI will work to establish clinical trials as a standard of care in treatment plans and to help achieve equitable cancer care delivery for all patients.

The Institute evolved from ACCC’s year-long examination of equity and access to clinical trials in the community under the direction of its Immediate Past President Randall A. Oyer, MD, who will lead a Task Force of recognized multidisciplinary cancer team professionals.

“Connecting community cancer centers through partnerships will help overcome persistent barriers that exist to conducting research in the community. By sharing resources, we can help make any community oncology program research-ready.”

Randall A. Oyer, MD
Medical Director,
Ann B. Barshinger Cancer Institute, Penn Medicine Lancaster General Health,
Lancaster, PA
ACCC 2020 - 2021 President


Three Primary Domains

EQUITY: We advocate for diversity, equity, and inclusion with trial sponsors and regulatory agencies. ACORI will develop education and resources that promote strategies and solutions to achieve health equity, as we investigate persistent areas of disparities in cancer clinical trial participation.

CAPACITY BUILDING: ACORI utilizes ACCC know-how to build capacity and competency among community research programs to make them research-ready by democratizing knowledge, skills, and infrastructure for clinical research. We will also facilitate mentorship opportunities between established and developing research programs and convene community oncology stakeholders for peer-to-peer learning and networking.

RESEARCH DIFFUSION: ACORI is a primary resource for academic and industry sponsors that fosters relationships with trial sponsors and other research groups. The Institute vets research and trial opportunities and disseminates pertinent opportunities to interested community oncology research programs.

Through ACCC’s robust network of partnerships, ACORI will enable community oncology programs and their multidisciplinary teams to access the tools, knowledge sharing, effective practices, and peer mentorships to increase their ability to offer trials to patients.

For more information about this project, please contact Victoria Zwicker, MPH, Program Manager, ACCC Provider Education.


Clinical Research Terms Glossary

This digital glossary of clinical research terms will help to establish a standardized understanding across cancer care team members and can serve as a tool to improve patient education and encourage shared decision-making conversations.

Access the Glossary

ACORI Call to Action Executive Summary

ACORI Executive SummaryThe ACORI Call to Action Summit: Activating Equity in Community Oncology Research—in collaboration with Stand Up to Cancer—identified concrete strategies for engaging patients, caregivers, and their communities to strengthen oncology research. More than 120 people from 60 organizations generated 200+ ideas for action items to make cancer care research more diverse, equitable, and accessible.

Download Now


ASCO-ACCC Collaborative 

ASCO and ACCC have joined forces to ensure that cancer treatment trials better reflect the diversity of cancer populations. The goal of the collaboration is to establish practical strategies and solutions to help increase participation in cancer treatment trials, with a focus on increasing clinical trial participation in patients from historically underrepresented racial and ethnic communities.

Seventy five research sites have signed on to participate in the pilot project, which aims to help ensure racial and ethnic diversity among clinical trial participants and support for clinicians so they are able to routinely offer clinical trials to all eligible patients.
Learn More



  • [PODCAST] Ep 84: Increasing Clinical Trial Access for Blood Cancers
    Jun 7, 2022

    Clinical trials are the best instrument to advance treatment for blood cancers, but numerous challenges exist around trial identification, enrollment, and participation. We’ll hear perspectives from a community provider and patient advocacy organization on immediate—and forward-thinking—solutions to help this population better access clinical trials, including a tool from the Leukemia and Lymphoma Society to help patients identify cancer clinical trials that may be a fit.

  • [MINI-PODCAST] Ep 38: Improving Community Clinical Trial Participation
    Oct 13, 2020

    Learn about the importance of reaching diverse populations with clinical trials where they live and how one clinical trial has prioritized community engagement.

On-Demand Webinars

  • The Association of Community Cancer Centers (ACCC) has established the ACCC Community Oncology Research Institute (ACORI) to build on its existing mission to close the gap in cancer research through optimal oncology partnerships. As part of this mission, ACCC hosted the ACORI Call to Action Summit, a two-day virtual event that explored practical solutions to strengthen and diversify oncology clinical trials in communities across the country.
    (Sep 13-14, 2021)


From Oncology Issues

Our Supporters

astrazeneca-200x80 merck-200x80 Sanofi-200x80

This project is supported by AstraZeneca, Merck, and Sanofi.